Want to join the conversation?
In 2Q16, $MNK's gross profit grew 3.6% versus 2Q15, mainly due to increased net sales from the inclusion of Inomax and Therakos. During 2Q16, gross profit included $2.1MM and $4.4MM, respectively, of expense associated with fair value adjustments of acquired inventory. Gross profit margin was 52.2% for the quarter.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.